Content uploaded by Chia-Ming Hsieh
Author content
All content in this area was uploaded by Chia-Ming Hsieh on Jan 04, 2014
Content may be subject to copyright.
18F-FDG PET in A Clinical Unsuspected Axillary Tuberculous
Lymphadenitis Mimicking Malignancy
Che-Ming Yang 1, Chung-Huei Hsu1, Chia-Ming Hsieh2, Mao-Yuan Chen3
1Department of Nuclear Medicine and PET Center, Taipei Medical University Hospital, Taipei, Taiwan
2Department of Surgery, Taiwan Adventist Hospital, Taipei, Taiwan
3Department of Pathology, Taiwan Adventist Hospital, Taipei, Taiwan
Received 01/28/2003; accepted 3/25/2003.
For correspondence or reprints contact: Chung-Huei Hsu, M.D., Department of
Nuclear Medicine, Taipei Medical University Hospital, 252 Wu-Hsing Street, Taipei
110, Taiwan. Tel: (886)2-27395748, Fax: (886)2-27395749,
E-mail: chhsu@tmu.edu.tw
Isolated axillary tuberculous lymphadenitis is rare. We
present a 33-year-old female who had palpable right
axillary masses without remarkable clinical symptom.
Ultrasound examination of breast and abdomen, mam-
mography, and chest radiography were negative. 18F-
Fluorodeoxyglucose positron emission tomography
(FDG-PET) study was misinterpreted as malignant dis-
ease extensively involving right axillary and the sur-
rounding lymph nodes, possibly metastatic occult
breast cancer. Tuberculous lymphadenitis was finally
proven by tissue biopsy. This potential pitfall should be
kept in mind when FDG-PET images are interpreted in
areas where the prevalence of granulomatous infection
is high.
Key words: FDG-PET, tuberculous lymphadenitis
Ann Nucl Med Sci 2003;16:107-110
Introduction
18F-Fluoro-2-deoxy-D-glucose (FDG) in conjunction
with positron emission tomography (PET) is a novel modali-
ty for tumor detection, staging, and therapeutic monitoring.
Its non-specificity remains a difficulty in differentiating
malignant from benign pathological variants which occasion-
ally mimic that of malignancy, especially in infectious and
non-infectious inflammatory foci with glucose hypermetabo-
lism [1-4]. The standard uptake value (SUV), 2.5 as cutoff
level, was commonly used as a supplementary tool for dis-
criminating benign from malignant [5]. However, various
intensities described as weak, intermediate, and strong FDG
uptake in tuberculosis (TB) infection had been reported pre-
viously [5-8].
Case Report
A 33-year-old female who had palpable right axillary
masses without clinical symptom was referred to our depart-
ment for a whole body FDG-PET study. Ultrasound examina-
tion of the breast and abdomen, mammography, chest radiog-
raphy, and physical examination of the breast were negative.
Occult breast cancer with lymph nodes metastases was clini-
cally suspected.
Whole body imaging was performed at 45 min and
additional focal delayed imaging was performed at 3 h after
intravenous injection of 259 MBq (7 mCi) of FDG on a
Siemens ACCEL PET scanner. Images were reconstructed
iteratively with attenuation correction.
The studies demonstrated intense circular uptake of
FDG in the right axillary region (maximal SUV = 8.7), spot-
like increased uptake in the right supraclavicular (SUV = 1.6)
and infraclavicular regions (SUV = 3.2) (Figures 1A and B).
The findings suggested malignant disease involving the right
axillary, supraclavicular, interpectoral, and subclavian lymph
nodes, possibly metastases from occult breast cancer.
Yang CM et al
Ann Nucl Med Sci 2003;16:107-110 Vol. 16 No. 2 June 2003
108
Echo-guided core needle biopsy of the axillary lymph
node was performed which showed granulomatous inflam-
mation with caseating necrosis (Figure 2). Tuberculous lym-
phadenitis was diagnosed.
Discussion
Primary presenting peripheral lymphadenopathy (LAP)
without constitutional symptoms is not unusual. In the neck,
the commonest causes in adults are metastatic, lymphoma-
tous, tuberculous, and inflammation reactive node [9,10].
Although isolated axillary mass is uncommon and the inci-
dence of occult breast cancer presenting as axillary metasta-
sis was low, lymphomatous tumor and metastatic occult
breast cancer are the leading pathological features account-
ing for about 50-60% of the abnormalities [11-14]. The
usage of FDG-PET for detecting the origin of a quiescent
lymph node of unknown primary site has been established
clinically [4,15].
Mycobacterium TB infection is a high prevalence dis-
ease in developing country and patients with immunocom-
promised disorder. In extrapulmonary TB, single cervical
lymph node was the most frequently involved site [10,16-
18]. Positive chest radiographic finding was not frequently
seen [16-18]. Intense uptake of FDG in mediastinal, supra-
clavicular, and pare-aortic tuberculous lymphadenitis had
been previously reported [5-7]. Axillary tubercolous LAP
was found in 41% of mammary TB as previously reported
[19]. However, the frequency of isolated axillary tuberculous
LAP is low [11,13].
References
1. Gutowski TD, Fisher SJ, Moon S, et al. Experimental
studies of 18F-2-fluoro-2-deoxy-D-glucose (FDG) in
infection and in reactive lymph nodes (abstract). J Nucl
Med 1992;33 (Suppl):P925.
2. Yamada S, Kubota K, Kubota R, et al. High accumula-
tion of fluorine-18-fluorodeoxyglucose in turpentine-
indiced inflammatory tissue (abstract). J Nucl Med
1995;36 (Suppl):P130.
3. Ichiya Y, Kuwabara Y, Sasaki M, et al. FDG-PET in
infectious lesions: The detection and assessment of
Figure 1. FDG-PET images performed (A) at 45 min and
(B) at 3 h on the position of hands-over-head revealed
intense uptake of tracer into right axillary and the surround-
ing lymph nodes.
Figure 2. Section of lymph node reveals caseating necrosis
with Langhan type giant cells on the periphery. The remain-
der lymphoid tissue is mainly mature small lymphocytes.
This pattern is strongly suggestive of tuberculosis. AFB
stain reveals some suspicious positive rods scattered in the
necrotic tissue.
AB
FDG PET
FDG PET of tuberculous lymphadenitis
2003;16:107-110 2003 616 2
109
lesion activity. Ann Nucl Med 1996;10:185-191.
4. Picard JD. Positron emission tomography in tumor
pathology. Bull Acad Natl Med 2000;184:1023-1029. [In
French].
5. Knight SB, Delbeke D, Stewart JR, Sandler MP.
Evaluation of pulmonary lesions with FDG-PET.
Comparison of findings in patients with and without a
history of prior malignancy. Chest 1996;109:982-988.
6. Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG
uptake in tuberculosis. Clin Nucl Med 1998;23:739-742.
7. Yen RF, Chen ML, Liu FY, et al. False-positive 2-[F-18]-
fluoro-2-deoxy-D-glucose positron emission tomography
studies for evaluation of focal pulmonary abnormalities.
J Formos Med Assoc 1998;97:642-645.
8. Cook GJ, Fogelman I, Maisey MN. Normal physiologi-
cal and benign pathological variants of 18-fluoro-2-
deoxyglucose positron-emission tomography scanning:
potential for error in interpretation. Semin Nucl Med
1996;26:308-314.
9. Ahuja A, Ying M. An overview of neck node sonogra-
phy. Invest Radiol 2002;37:333-342.
10. Abba AA, Bamgboye AE, Afzal M, Rahmatullah RA.
Lymphadenopathy in adults. A clinicopathological analy-
sis. Saudi Med J 2002;23:282-286.
11. de Andrade JM, Marana HR, Sarmento Filho JM, Murta
EF, Velludo MA, Bighetti S. Differential diagnosis of
axillary masses. Tumori 1996;82:596-599.
12. Foroudi F, Tiver KW. Occult breast carcinoma presenting
as axillary metastases. Int J Radiat Oncol Biol Phys
2000;47:143-147.
13. Walsh R, Kornguth PJ, Soo MS, Bentley R, DeLong
DM. Axillary lymph nodes: mammographic, pathologic,
and clinical correlation. AJR Am J Roentgenol
1997;168:33-38.
14. Murray ME, Given-Wilson RM. The clinical importance
of axillary lymphadenopathy detected on screening
mammography. Clin Radiol 1997;52:458-461.
15. Block EF, Meyer MA. Positron emission tomography in
diagnosis of occult adenocarcinoma of the breast. Am
Surg 1998;64:906-908.
16. Jha BC, Dass A, Nagarkar NM, Gupta R, Singhal S.
Cervical tuberculous lymphadenopathy: changing clini-
cal pattern and concepts in management. Postgrad Med J
2001;77:185-187.
17. Mert A, Tabak F, Ozaras R, Tahan V, Ozturk R, Aktuglu
Y. T uberculous lymphadenopathy in adults: a review of
35 cases. Acta Chir Belg 2002;102:118-121.
18. Aggarwal P, Wali JP, Singh S, Handa R, Wig N, Biswas
A. A clinico-bacteriological study of peripheral tubercu-
lous lymphadenitis. J Assoc Physicians India
2001;49:808-812.
19. Khanna R, Prasanna GV, Gupta P, Kumar M, Khanna S,
Khanna AK. Mammary tuberculosis: report on 52 cases.
Postgrad Med J 2002;78:422-424.
Yang CM et al
Ann Nucl Med Sci 2003;16:107-110 Vol. 16 No. 2 June 2003
110
-18
1123
1
2
3
33 X
-18
-18
2003;16:107-110
92 128 92 325
110 252 (02)-27395748 (02)-27395749 chhsu@tmu.edu.tw